Città di Torino
Città della Scienza e della Salute di Torino
Regione Piemonte
Rete Oncologica Piemonte e Val D'Aosta


CPO Piemonte
Fondazione Edo ed Elvo Tempia


The International Cancer Screening Network (ICSN) is a consortium of countries, organizations, and experts interested in promoting multidisciplinary context-specific population cancer screening through evidence-based strategies. ICSN aims to evaluate implementation of cancer screening, and discuss methods for improving the quality and effectiveness of the programs.

Participation in the ICSN is open to any country or region that has initiated or is considering the implementation of a population-based cancer screening program.

ICSN members have formed interest groups focused on targeted research, data collection, and assessment of screening strategies tailored to the country context. Established interest groups that will meet preceding the ICSN 2023 include:

  • Cervical Cancer Screening
  • Colorectal Cancer Screening

(Start-up sessions of new working groups can also be organised by interested people)

ICSN 2023 will provide an opportunity for international experts to exchange knowledge, research methods, practice challenges, and results in the field of cancer screening; and, to prioritize, develop and move forward research projects through interest and working groups. ICSN 2023 sessions will include research relevant to:

  • Risk-based screening
  • Blood/Multi-cancer test
  • Screening as a research platform
  • New technologies and screening tests
  • Integrating primary and secondary prevention
  • Alternative approaches to implement screening as a public health intervention
  • Best practices
  • Communication issues
  • Hard-to-reach populations/Equity in cancer screening
  • Meeting the clinicians
  • Monitoring, evaluation and quality assurance

New screening programmes


After two years of health emergency, the next meeting of the International Cancer Screening Network, on June 21st-23rd, 2023, bringing together screening experts in several disciplines from all around the world, will offer the opportunity to share lessons learnt during the Covid 19 pandemic and to restart the screening activities with new impulses and renewed energy.

The event’s program will address various topics from new approaches to optimize screening and the potential contribution of new technologies to screening for established or new cancer sites.

The experience of using risk-based criteria for prioritization of delayed invitations showed that the adoption of this approach is expected to maximize the benefits and minimize the harms of screening and is now piloted in several settings.  Incorporating advances in genomics and biomarkers research in the screening process can offer new opportunities for a more precise risk assessment and for enhancing cost-effectiveness of screening. Moreover, a new era of early cancer detection with blood tests may change cancer screening paradigms.

Implementing new approaches requires collaboration between various stakeholders, policy makers and healthcare professionals, and the development of research efforts within ongoing screening programs.

It also requires the adoption of new and effective strategies to ensure equity of access and informed decisions for persons invited to attend cancer screening programs, avoiding exclusion of vulnerable sub-groups. Systematic monitoring and evaluation of screening programs’ performance will be necessary to support these innovations as well ensure quality of ongoing programs.

Other important issues addressed in this meeting include the integration of primary and secondary cancer prevention and communication with the screening target population as well as among health professionals.

Established interest working groups will also have the opportunity to meet again in person before the meeting to review achievements of their online activities during the past months and to plan new initiatives.

ICSN 2023 will be organized in Turin, North-West of Italy, and it will be again in person, four years since the last meeting in 2019. Apart from the session, the meeting will offer ample opportunities to network and interact with ICSN members. The health emergency has stranded us for two long years strongly affecting also our human relationships. Now it is time to restart. Welcome to Turin ICSN 2023!


February 25, 2023:
Abstract submission deadline

March 31, 2023:
Abstract acceptance notification

April 27, 2023:
Early Registration deadline for presenters of accepted abstracts

June 14, 2023:
Registration deadline

June 21-23, 2023:
Conference dates


9.00 amRegistration

9.30 amWorking groups
– Colorectal cancer
– Breast cancer

10.30 amWorking groups
– Cervical cancer

Chairs: Mireille Broeders, Livia Giordano, Carlo Senore
Welcome by the Local Authorities
Giovanni La Valle, General Manager – AOU Città della salute e della scienza di Torino
Massimo Aglietta, Coordinator – Rete Oncologica Piemonte
Jacopo Rosatelli, Deputy Mayor in charge of Social Policies, Rights and Equalities 

1.50 pmWelcome by the Steering Committee
Mireille Broeders, ICSN Chair

2.00 pmWelcome by the Planning Committee
Livia Giordano, ICSN 2023 Meeting Co – Chair and CPO Piemonte
Carlo Senore, ICSN 2023 Meeting Co – Chair and CPO Piemonte
Viola Erdini, President – Fondazione Edo ed Elvo Tempia
Welcome by Sermig

2.10 pmIntroduction
Key note speech
Nereo Segnan 

2.30 pmPlenary Session 1
Risk-based Screening
Chairs: Mireille Broeders, Guglielmo Ronco

4.15 pmCoffe Break
Country corner

5.00 pmConcurrent Session 1
Blood/Multi-cancer Test
Chair: Robert Smith, Ruth Etzioni

5.00 pmConcurrent Session 2
Screening as a Research Platform
(Screening as an Opportunity to Contribute to Research)
Chairs: Carlo Senore, Chyke Doubeni 

7.00 pmSocial event
Lecture “Art and Screening”
Alfonso Frigerio

7.30 pmSocial event
Welcome Reception

9.00 amPlenary Session 2
New Technologies and Screening Tests
Chairs: Miriam Elfström, Paolo Giorgi Rossi

10.45 amCoffee Break
Country corner

11.30 amConcurrent Session 3
Integrating Primary and Secondary Prevention
Chairs: Nereo Segnan, David Weller

11.30 amConcurrent Session 4
Comparing Alternative Approaches to Implement Screening as a Public Health Intervention
Chairs: Linda Rabeneck, Christine Campbell

1.00 pmLunch & Poster Session I

2.15 pmPlenary Session 3
Monitoring, Evaluation and Quality Assurance
Chairs: Elsebeth Lynge, Partha Basu

4.00 pmCoffee Break
Country corner

4.45 pmConcurrent Session 5
Communication Issues
Chairs: Andrea Burón, Anath Flugelman

4.45 pmConcurrent Session 6
Data System and Legal Framework
Chairs: Jean-Luc Bulliard, Paul Doria-Rose

8.30 pmSocial event
Social dinner

9.00 amPlenary Session 4
Hard-to-Reach Populations – Equity in Cancer Screening
Chairs: Livia Giordano, Michelle Silver

10.45 amCoffe Break
Country corner

11.30 pmConcurrent Session 7
Best Practices: the impact of COVID-19 on Cancer Screening
Chairs: Iris Landsdorp-Vogelaar, Douglas Perin

11.30 amConcurrent Session 8
Screening and Clinical Medicine
Chairs: Antonio Ponti, Robert Schoen

1.00 pmLunch & Poster Session II

2.15 pmPlenary Session 5
New Screening Programmes
Chairs: Harry de Koning, Beatrice Lauby-Secretan

4.00 pmClosing remarks


*The programme may be subject to change without prior notice.

Discover Turin and download the facilitation voucher reserved for Congress participants.

Poster presentations are now available for download.


(until April 27, 2023)
(after April 27, 2023)
Standard Delegate 650,00 € 750,00 €
Low Income Countries* 550,00 € 550,00 €
Social dinner 55,00 € 55,00 €

* Afghanistan, Burkina Faso, Burundi, Central African Republic, Chad, Congo, Dem. Rep., Eritrea, Ethiopia, Gambia, The Guinea, Guinea-Bissau, Korea, Dem. People’s Rep., Liberia, Madagascar, Malawi, Mali, Mozambique, Niger, Rwanda, Sierra Leone, Somalia, South Sudan, Sudan, Syrian Arab Republic, Togo, Uganda, Yemen, Rep., Zambia

Online registrations
are now closed.

(until April 27, 2023)
Standard Delegate650,00 €
Low Income Countries*550,00 €
Social dinner55,00 €
(after April 27, 2023)
Standard Delegate750,00 €
Low Income Countries*550,00 €
Social dinner55,00 €

* Afghanistan, Burkina Faso, Burundi, Central African Republic, Chad, Congo, Dem. Rep., Eritrea, Ethiopia, Gambia, The Guinea, Guinea-Bissau, Korea, Dem. People’s Rep., Liberia, Madagascar, Malawi, Mali, Mozambique, Niger, Rwanda, Sierra Leone, Somalia, South Sudan, Sudan, Syrian Arab Republic, Togo, Uganda, Yemen, Rep., Zambia

Online registrations
are now closed.


Please note that:

  • the registration fee includes all refreshments, including welcome reception
  • payment will be accepted by Credit Card or PayPal
  • registration fees must be paid in euros
  • the Social Conference Dinner is optional


Cancellation has to be made by e-mail to the Conference Secretariat (c.magri@planning.it). If a cancellation is received before or on April 29, 2023 the registration fee will be reimbursed minus EUR 75,- handling charges. After this date, or if registrants fail to attend the conference for any reason whatsoever, regrettably no refund can be made.


Thursday June 22, 2023 from 20.30 onwards

55 € to be paid when registering for the conference (those who have already registered for the conference can also register for the social dinner by purchasing it here)

Registration deadline
Wednesday June 21, 2023

Buffet: Piedmontese cheese and salami Artisanal pizza and focaccia House-made Pan Brioche Crostini with smoked trout from Monregalese, soy sauce and dill mayonnaise Mini Oriental Poke Bowl (sushi rice, marinated salmon, edamame, cashews, teriyaki sauce) Veal with tuna sauce roll and citrus caramel Sweet Pastrami Sandwich with Piemontese Razza, sweet pickles, and mustard Mini Fassoneria Burgers Grana cheese flan with tomato concasse and zucchini Fried mozzarella sandwiches Sage fritters
First Course: Piedmontese Ravioli with ‘d Muncalè sausage ragù
Beverages: Valdobbiadene Prosecco, Dolcetto, and Arneis wines from Bosio wineries fruit juices, non-alcoholic options

Porto Urbano

Murazzi del Po Gipo Farassino, 15
10124 – Turin, Italy

Porto Urbano is developed on the right side of the Murazzi in the former arcades of Magazzini Devalle, the old boathouses located on the west bank of the Po. It is a multifunctional space with four arches and two large outdoor areas to enjoy one of the most beautiful views of the city: the sight of the hill reflecting on the river.



  • Once you have submitted your abstract, you will receive an automatic email confirmation.
    If you do not receive an email, please email the Organizing Secretariat (c.magri@planning.it).
  • All abstracts will be reviewed, scored and accepted or rejected by the Scientific Committee.
    The decision of the Committee is final.
  • You will be notified of your submission’s acceptance status via e-mail by March 31, 2023.
  • If an abstract is accepted for presentation, the presenting author must attend the Conference to present the abstract. The presenting author will be required to register for the Conference by April 20, 2023 in order to have the abstract acceptance confirmed. If a presenting author is not registered by that date, the Scientific Committee will remove the abstract from the program.
  • Abstract presenters will be required to fund in full their own attendance at the conference (including conference registration and travel expenses) and should not accept to present an abstract if this is not possible.

Abstract submission is now closed.

Scan this QR code, download the ICSN 2023 App and enhance your conference experience by getting access to posters, oral presentations and more:



Mireille Broeders

PhD, ICSN Chair (until Dec 2023)
Professor of Personalized Screening at Radboud University Medical Center, Netherlands
Currently chairs ICSN

Miriam Elfström

PhD, ICSN Chair-elect (becomes Chair Jan 2024)
Karolinska Institute, Sweden
Dr. Elfström is the Chair-Elect of ICSN and will be the next to take on the leadership of the network


Jean-Luc Bulliard – PhD – University of Lausanne, Switzerland

Andrea Burón – MD PhD MPH – Hospital del Mar, Spain

Christine Campbell – PhD MPH – University of Edinburgh, United Kingdom

Harry de Koning – MD PhD – Erasmus University Medical Center, Netherlands

Paul Doria-Rose – DVM PhD – U. S. National Cancer Institute, United States

Anath Flugelman – MD MPH – Ruth and Bruce Rappaport Faculty of Medicine, Israel

Elsebeth Lynge – PhD – University of Copenhagen, Denmark

Aruna Kamineni – PhD MPH – Kaiser Permanente Washington Health Research Institute, United States

Douglas Perin – JD MPH – Leidos Biomedical Research Inc./U. S. National Cancer Institute, United States

Antonio Ponti – MD MPH – (formerly at) Cancer Prevention Center (CPO), Italy

Linda Rabeneck – MD MPH – Cancer Care Ontario, Canada

Nereo Segnan – MD MSc – (formerly Head of) Cancer Prevention Center (CPO), Italy

Robert Smith – PhD – American Cancer Society, United States

David Weller – PhD – University of Edinburgh, United Kingdom


Livia Giordano – Epidemiology and Screening Department – CPO Piemonte, AOU Città della Salute, Turin, Italy

Carlo Senore – Epidemiology and Screening Unit – CPO Piemonte, AOU Città della Salute, Turin, Italy

Silvia Deandrea – GISMa, Italian Group for Mammography Screening, Italy

Alfonso Frigerio – Center for Mammography Screening, Italy

Tiziano Maggino GISCi, Italian Cervical Cancer Screening Group, Italy

Paola Mantellini – ONS – National Screening Observatory, Italy

Antonio Ponti – MD MPH – (formerly at) Cancer Prevention Center (CPO), Italy

Pietro Presti – Fondazione Tempia, Italy

Nereo Segnan – MD MSc – (formerly Head of) Cancer Prevention Center (CPO), Italy


Anderson Benjamin O. – Geneva, Switzerland

Armaroli Paola – Turin, Italy

Arrossi Silvina – Mexico

Atakpa Emma C. – London, United Kingdom

Basu Partha – Lyon, France

Camussi Elisa – Turin, Italy

Castan-Cameo Susana – Valencia, Spain

Chen Cay Yu-Ching – Taiwan

Chen Tony Hsiu-Hsi – Taiwan

Chiarelli Anna M. – Toronto, Canada

Corley Douglas A. – Northern California, United States

De Jonge Lucie – Rotterdam, Netherlands

De Nijs Koen – Rotterdam, Netherlands

Di Stefano Francesca – Turin, Italy

Dibden AmandaLondon, United Kingdom

Doubeni Chyke – Ohio, United States

Doyle Gregory – Canada

Etzioni Ruth – Unites States

Gabe Rhian – London, United Kingdom

Garcia Montse – Barcelona, Spain

Gertig Dorota – Melbourne, Australia

Giorgi Rossi Paolo – Reggio Emilia, Italy

Gizaw Muluken* – Addis Ababa, Ethiopia

Gouessé Rita-Josiane* – Jhpiego, Côte D’Ivoire

Gravitt Patti E. – Washington, Unites States

Haug Ulrike – Germany

Heinävaara Sirpa – Helsinki, Finland

Helgestad Anne Dorte Lerche – Aarhus, Denmark

Hsu Chen-Yang – Taipei, Taiwan

J. Subramanian Malliga* – India

Jen Hsiao Hsuan Taipei, Taiwan

Kabue Mark*Baltimore, United States

Kim Yeol – Korea

Kirkegaard Pia – Randers, Denmark

Kohler Racquel – New Brunswick, United States


*Winner of a scholarship supported by the US National Cancer Institute

Kregting Lindy – Rotterdam, Netherlands

Li Xue* – Hangzhou, China

Lin Ting-Yu – Taipei, Taiwan

Majek Ondrej – Prague, Czech Republic

Mantellini Paola – Firenze, Italy

McIntosh Jennifer – Melbourne, Australia

Minasian LoriBethesda, Unites States

Mosquera Isabel – France

Munpolsri Pattaranan – Taipei, Taiwan

Nethan Suzanne – Lyon, France

Ngo Ondrej – Prague, Czech Republic

Njor Sisse – Randers, Denmark

O’Connor Mairead – Dublin, Ireland

Oommen Anu Mary – Tamil Nadu

Panera Jon Aritz – Spain

Pignone Michael – Austin, United States

Ribbing Wilén Hanna – Stockholm, Sweden

Robb Kathryn A. – Glasgow, United Kingdom

Robbins Hilary – France

Ronco Guglielmo – Turin, Italy

Sasieni Peter – London, United Kingdom

Schoen Robert – Pittsburg, United States

Seriese Iris – Bilthoven, Netherlands

Sheridan Brian – Netherlands

Silver Michelle – St. Louis, United States

Solmundson Joanne – Canada

Su Chiu-Wen – Taiwan

Toes-Zoutendijk Esther – Netherlands

Usher-Smith Juliet – Cambridge, United Kingdom

Van Dijck Jos – Nijmegen, Netherlands

Van Keer Severien – Antwerp, Belgium

Van Wifferen Francine – Amsterdam, Netherlands

Vyskot Tomas – Prague, Czech Republic

Zheng Senshuang – Groningen, Netherlands


Sermig – Arsenal of peace
Piazza Borgo Dora, 61
10152 – Turin, Italy
Phone: +39.011.4368566
E-mail: sermig@sermig.org

It once was an arsenal of war, a factory of weapons, but, since 1983, the free work of thousands of people transformed it into an Arsenal of Peace.



From North Ringroad
Barriera Falchera exit, continue along Corso Giulio Cesare, turn on Lungo Dora Napoli and follow signs for Sermig-Arsenale della Pace

From South Ringroad
Corso Unità d’Italia exit, follow the signs for the city centre


From Porta Nuova railway station
Bus line 11, tram line 4

From Porta Susa railway station
Bus lines 19, 51, 57


The international “Torino Airport” is 16 km away from the city centre: it can be reached in 30’ by taxi (on the left at the exit of the Arrival level) or with the ARRIVA bus service.


Visa requirements

Information on Visa requirements can be found at schengenvisainfo.com

What to do in Turin

For information on what to do in Turin please visit turismotorino.org and Associazione Torinese Tram Storici


Book your hotel accommodation at special rates by selecting the hotel that best suits you: booking.incomingexperience.it

For any further assistance or request please contact our booking office: reservation@incomingexperience.it

Consorzio Turistico Incoming Experience
Via Berthollet 19,
10125 Turin (Italy)
Phone +39  0116505309

Alberto Marchetti
Turismo | Torino e provincia
Copyright 2022 Prospero Multilab Srl. Tutti i diritti riservati.